Times Square Capital Management, LLC Argenx Se Transaction History
Times Square Capital Management, LLC
- $6.24 Billion
- Q3 2025
A detailed history of Times Square Capital Management, LLC transactions in Argenx Se stock. As of the latest transaction made, Times Square Capital Management, LLC holds 127,530 shares of ARGX stock, worth $116 Million. This represents 1.51% of its overall portfolio holdings.
Number of Shares
127,530
Previous 133,580
4.53%
Holding current value
$116 Million
Previous $73.6 Million
27.75%
% of portfolio
1.51%
Previous 1.14%
Shares
31 transactions
Others Institutions Holding ARGX
# of Institutions
526Shares Held
26MCall Options Held
590KPut Options Held
320K-
Price T Rowe Associates Inc Baltimore, MD3.64MShares$3.31 Billion0.29% of portfolio
-
Janus Henderson Group PLC London, X02.58MShares$2.34 Billion0.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.19MShares$1.99 Billion2.46% of portfolio
-
Capital World Investors Los Angeles, CA1.96MShares$1.78 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY1.01MShares$918 Million0.01% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $50.2B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...